Opko Health Inc. 

(Public, AMEX:OPK)   Watch this stock   
Find more results for OPK
Nov 17, 2009
Lazard Capital Healthcare Conference
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin -418.99% -421.97%
Operating margin -390.01% -408.51%
EBITD margin - -389.44%
Return on average assets -35.20% -129.90%
Return on average equity -49.94% -467.80%
Employees 57 -

Address

4400 Biscayne Blvd. Suite 1180
Miami, FL 33137
United States - Map
+1-305-5756015 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance

Opko Health Inc. discussions

  View all discussions »

Description

Opko Health Inc. is a specialty healthcare company. The Company is focused on the discovery, development and commercialization of pharmaceuticals, drug delivery technologies, diagnostic systems, and instruments for the treatment, diagnosis and management of ophthalmic diseases and conditions. Its business consists of the development of ophthalmic pharmaceuticals and the development, commercialization and sale of ophthalmic diagnostic and imaging systems and instrumentation products. It focuses on exploring opportunities to acquire complementary pharmaceuticals, compounds, and technologies, which could, individually or in the aggregate, materially increase the scale of the Company’s business. On May 6, 2008, the Company completed the acquisition of Vidus Ocular, Inc. (Vidus).

Officers and directors

Phillip Frost M.D.
Chairman of the Board, Chief Executive Officer
Age: 73
Bio & Compensation - Reuters
Jane H. Hsiao Ph.D.
Vice Chairman of the Board, Chief Technical Officer
Age: 62
Bio & Compensation - Reuters
Subbarao V. Uppaluri Ph.D.
Chief Financial Officer, Senior Vice President
Age: 60
Bio & Compensation - Reuters
Steven D. Rubin
Executive Vice President - Administration, Director
Age: 49
Bio & Compensation - Reuters
Jamie Freedman M.D., Ph.D.
Executive Vice President - R&D and Business Development
Bio & Compensation - Reuters
John A. Paganelli
Director
Age: 73
Bio & Compensation - Reuters
Robert A. Baron
Director
Age: 69
Bio & Compensation - Reuters
Richard A. Lerner M.D.
Director
Age: 70
Bio & Compensation - Reuters
Pascal J. Goldschmidt M.D.
Director
Age: 54
Bio & Compensation - Reuters
Richard C. Pfenniger Jr.
Director
Age: 54
Bio & Compensation - Reuters